Skip to content

Valion Bio, Inc.

VBIO

CIK 0001787740 · Pharmaceutical Preparations · Nasdaq

  • Tivic Health Systems, Inc. (until 2026-04-23)
← back to feed
Revenue (TTM)
—
Q1 May 2026
Net Income (TTM)
−$12.23M
−57.0% YoY Q1 May 2026
EPS Diluted (TTM)
−$10.31
+88.9% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$10.1M
Q1 May 2026
Cash
$7.22M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
3.2M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings